ITCMDBv1
Clinical TrialID 446

Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

NCT02213562

Hyperuricemia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
446
Evidence Id
446
Core Evidence Id
446
Source Clinical Trial Id
432
Herb2 Clinical Trial Id
HBCT000432
Nct Id
NCT02213562
Title
Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia
Status
Completed
Phase
Study Result
No
Study Condition
Hyperuricemia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Intervention
DIETARY_SUPPLEMENT: 200 mg of chrysanthemum flower oil|DIETARY_SUPPLEMENT: 300 mg of chrysanthemum flower oil|DIETARY_SUPPLEMENT: 400 mg of chrysanthemum flower oil
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Triple
Intervention Purpose
Prevention
Gender
Male
Age
Adult
Enrollment
21
Outcome Measure
Change in serum uric acid from baseline, Every 4 weeks (Overall 8 weeks)|Change in uric acid clearance from baseline, Every 4 weeks (Overall 8 weeks)
Sponsor Collaborator
Hiroshima University|Kaneka Corporation
Funded By
OTHER
Location
Hiroshima University, Hiroshima, 734-8551, Japan
Other Id
eki-997
Start Date
2014-07
Primary Completion Date
2016-03
Completion Date
2016-03
First Posted
2014-08-11
Results First Posted
Last Update Posted
2016-08-17
Study Document
Study Url
https://clinicaltrials.gov/study/NCT02213562
Title Cn
Title En
Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia
Bilingual Status
semi_complete